|
- The Coca-Cola Company to Refile Hart-Scott-Rodino and Canadian Pre-Merger Notifications
ATLANTA--(BUSINESS WIRE)--The Coca-Cola Company (NYSE: KO) announced today that it has withdrawn and will refile its notification and report forms filed with the Federal Trade Commission (FTC) in order to provide the FTC additional time to review the Company's proposal to acquire Coca-Cola Enterprises' (CCE) North American bottling business. In addition, the Company announced that it has ...
canadian tax form 31 Jul 2010 - Economists decry census move
More than 75 per cent of group surveyed do not believe its good policy to replace mandatory long-form census with a voluntary household survey
canadian tax form 31 Jul 2010 - Canadian Pacific announces second-quarter results
Canadian Pacific Railway Limited today announced second-quarter net income of $166.6 million. Diluted earnings per share were $0.98, up 23 per cent from $0.80 in the second-quarter 2009 which included a $0.41 per share gain from an asset sale.
canadian tax form 31 Jul 2010 - Obama says he'll call Republicans' bluff on deficit talk and offer his own ideas
WASHINGTON - President Barack Obama has a warning for Republicans who denounce the federal deficit but reject proposals to cut it.
canadian tax form 31 Jul 2010 - Walkom: A day with the Liberal Express tour
On Day 13 of his cross-country image-repair tour, Michael Ignatieff is less scary but still vague.
canadian tax form 31 Jul 2010 - Canadian life insurers concerned with new global accounting rules
Canadian life insurers have 'concerns' about the impact on capital levels of new global accounting standards released in draft form Friday that appear to disrupt the matching on their balance sheets of long-term obligations with long-term investments
canadian tax form 31 Jul 2010 - MethylGene Reports Second Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
MONTREAL, QUEBEC--(Marketwire - July 30, 2010) - MethylGene Inc. (TSX:MYG) today announced financial results for the second quarter ended June 30, 2010. In addition, the Company provided a clinical trial update for its multi-targeted (Met) kinase oncology inhibitor, MGCD265. Financial Results Reported in Canadian Dollars
canadian tax form 31 Jul 2010
|